![]() |
Volumn 23, Issue 5, 2003, Pages 690-694
|
Dose conversion from epoetin alfa to darbepoetin alfa for patients with chronic kidney disease receiving hemodialysis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
RECOMBINANT ERYTHROPOIETIN;
ARTIFACT;
CHRONIC KIDNEY DISEASE;
CONFIDENCE INTERVAL;
DOSE CALCULATION;
DRUG MEGADOSE;
DRUG STABILITY;
EXPERIMENTAL MODEL;
HEMODIALYSIS;
HEMOGLOBIN DETERMINATION;
HUMAN;
NONLINEAR SYSTEM;
REVIEW;
STATISTICAL SIGNIFICANCE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
EPOETIN ALFA;
ERYTHROPOIETIN;
HEMATINICS;
HUMANS;
KIDNEY FAILURE, CHRONIC;
RENAL DIALYSIS;
THERAPEUTIC EQUIVALENCY;
|
EID: 0037967394
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.23.5.690.32195 Document Type: Review |
Times cited : (18)
|
References (2)
|